Details for Patent: 7,863,287

Which drugs does patent 7,863,287 protect, and when does it expire?

Patent 7,863,287 protects ADVIL ALLERGY SINUS and is included in one NDA.

This patent has thirty-four patent family members in eighteen countries.

Summary for Patent: 7,863,287

Title:	Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
Abstract:	The present invention is directed to a pharmaceutical composition and method for the treatment of rhinitis and cold-like symptoms which includes a non-steroidal anti-inflammatory drug (NSAID), a decongestant, and an antihistamine. It has been found that an NSAID enhances the activity of a decongestant and an anti-histamine, thus permitting a reduction in either or both in administration of separate dosage forms. The same enhancement can also occur with an anti-tussitive. Thus, the effective amount of the decongestant or the antihistamine or both is less than about 75% of an amount present in an approved dose of the decongestant or the antihistamine, or both, relative to an amount of the NSAID corresponding to about 100% of the amount present in a normal strength dosage form of the NSAID.
Inventor(s):	Roger G. Berlin
Assignee:	Haleon US Holdings LLC
Application Number:	US10/740,386
Patent Claim Types: see list of patent claims	Composition; Formulation; Dosage form;

Drugs Protected by US Patent 7,863,287

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Haleon Us Holdings	ADVIL ALLERGY SINUS	chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride	TABLET;ORAL	021441-001	Dec 19, 2002		OTC	Yes	Yes	7,863,287		Y

International Family Members for US Patent 7,863,287

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	042543
Australia	2003301188
Australia	2005251733
Australia	2011200912
Canada	2508611